Novartis subsidiary Sandoz launched a generic challenger to AbbVie’s Combigan on Thursday. The debut came less than two weeks after the FDA approved the generic ophthalmic solution. Its arrival marks ...
Glenmark has received the Food and Drug Administration’s permission for brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%|0.5%, which is the ...
NEW YORK, Oct 31 (Reuters) - Allergan Inc on Wednesday said U.S. regulators approved its glaucoma drug Combigan, an eye drop which treats the potentially blinding eye condition with two drugs that ...
To reduce elevated intraocular pressure (IOP) in glaucoma or ocular hypertension where adjunctive or replacement therapy is warranted. Combigan contains two drugs widely used in the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback